These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3831470)

  • 21. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
    Nakamichi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibrinogen-fibrin degradation products in renal disorders.
    Dube B; Srivastava PK; Padmanabhan R; Dube RK
    Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary fibrin/fibrinogen derivatives.
    Hedner U
    Thromb Diath Haemorrh; 1975 Dec; 34(3):693-708. PubMed ID: 54945
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of a test for soluble fibrin polymer (TpP) with a standard quantitative ELISA for D-dimer in patients, without current thrombosis, who have cancer or renal disease.
    Arkel YS; Ku DH; Le P; Carr AM
    Thromb Haemost; 2001 Oct; 86(4):1127-8. PubMed ID: 11686342
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].
    Panchenko VM; Gilunova NI; Kozhomkulova BZh
    Lab Delo; 1977; (8):451-4. PubMed ID: 72846
    [No Abstract]   [Full Text] [Related]  

  • 26. [Kinetic alterations of coagulation-anticoagulation and the fibrinolytic system in patients with epidemic hemorrhagic fever and their significance].
    Dong CR
    Zhonghua Yi Xue Za Zhi; 1988 Dec; 68(12):678-81, 46. PubMed ID: 2907863
    [No Abstract]   [Full Text] [Related]  

  • 27. [Relations between products of fibrin degradation and arterial blood pressure in pregnancy complicated by nephropathy].
    Tsitsiashvili ESh
    Lab Delo; 1982; (4):230-2. PubMed ID: 6177910
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fibrin degradation products (FDP) and fibrinolytic activity of blood in various acute and chronic diseases].
    Kotschy M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):425-30. PubMed ID: 63429
    [No Abstract]   [Full Text] [Related]  

  • 29. [The fibrinogen-fibrin-fibrinolysis system in rheumatoid arthritis].
    Belitskaia GA; Palienko IA; Shevchenko LI; Fedorova NE
    Vrach Delo; 1989 Jan; (1):47-50. PubMed ID: 2718445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical observations on renal vein blood fibrin degradation products (FDP) in glomerulonephritis (author's transl)].
    Tomura S
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):233-44. PubMed ID: 470233
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    Thomas DP; Niewiarowski S; Myers AR; Bloch KJ; Colman RW
    N Engl J Med; 1970 Sep; 283(13):663-8. PubMed ID: 4247823
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrin in renal disease: functional considerations.
    Wardle EN
    Clin Nephrol; 1974; 2(3):85-92. PubMed ID: 4604477
    [No Abstract]   [Full Text] [Related]  

  • 34. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Platelets and fibrinolytic enzyme systems in renal artery and vein (author's trsnsl)].
    Kono N; Mizokami T; Hashimoto T; Okishio N; Yagishita A
    Nihon Hinyokika Gakkai Zasshi; 1980 Jan; 71(1):20-7. PubMed ID: 7382222
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thrombocyte function and fibrinogen degradation products in glomerulonephritis].
    Fazlyeva RM
    Klin Med (Mosk); 1978 Nov; 56(11):75-81. PubMed ID: 723202
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
    Chuecas F; Loredo E; Muñoz B; Alfaro J; Grebe G; Lira P
    Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular hemostasis in normal and pathologic conditions.
    Sraer JD; Kanfer A; Rondeau E; Lacave R
    Adv Nephrol Necker Hosp; 1988; 17():27-55. PubMed ID: 3124541
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood coagulation in normotensives and hypertensives in relation to their body mass index].
    Franz IW; Van Der Meyden J; Tönnesmann U; Müller JF; Röcker L; Hopfenmüller W
    Dtsch Med Wochenschr; 2002 Nov; 127(45):2374-8. PubMed ID: 12422294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.